{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:24:20Z","timestamp":1773681860244,"version":"3.50.1"},"reference-count":47,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1649,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1002\/art.30186","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T12:48:58Z","timestamp":1292417338000},"page":"654-661","source":"Crossref","is-referenced-by-count":36,"title":["Particular association of clinical and genetic features with autoimmunity to citrullinated \u03b1-enolase in rheumatoid arthritis"],"prefix":"10.1002","volume":"63","author":[{"given":"Ariana","family":"Montes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Dieguez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Perez-Pampin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Calaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mera-Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Gomez-Reino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,25]]},"reference":[{"key":"10.1002\/art.30186-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB2|cit2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB4|cit4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/BOR.0b013e3282fbd22a","article-title":"Antibodies to citrullinated proteins in arthritis: pathology and promise","volume":"20","author":"Klareskog","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1002\/art.30186-BIB5|cit5","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"Van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30186-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/art.22868","article-title":"The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register","volume":"56","author":"Bukhari","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB7|cit7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","article-title":"Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease","volume":"46","author":"Machold","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30186-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10067-006-0462-4","article-title":"Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids","volume":"26","author":"Sanmarti","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1002\/art.30186-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/art.23439","article-title":"Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies","volume":"58","author":"De Vries-Bouwstra","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB10|cit10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/acr.20207","article-title":"Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies","volume":"62","author":"Farragher","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1002\/art.30186-BIB11|cit11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/ard.2007.084715","article-title":"Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis","volume":"68","author":"Potter","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30186-BIB12|cit12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pharmthera.2010.01.001","article-title":"Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers","volume":"125","author":"Dorner","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1002\/art.30186-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"Van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB15|cit15","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2214","article-title":"The PTPN22 1858C\/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden","volume":"9","author":"Kokkonen","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30186-BIB16|cit16","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1371\/journal.pmed.0040278","article-title":"A candidate gene approach identifies the TRAF1\/C5 region as a risk factor for rheumatoid arthritis","volume":"4","author":"Kurreeman","year":"2007","journal-title":"PLoS Med"},{"key":"10.1002\/art.30186-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.23426","article-title":"Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis","volume":"58","author":"Dieguez-Gonzalez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.23549","article-title":"Association of STAT4 with rheumatoid arthritis: a replication study in three European populations","volume":"58","author":"Orozco","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB19|cit19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB20|cit20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2005.041079","article-title":"Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles","volume":"65","author":"Linn-Rasker","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30186-BIB21|cit21","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","article-title":"Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides","volume":"8","author":"Pedersen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30186-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/art.22703","article-title":"Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB23|cit23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.27272","article-title":"Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status","volume":"62","author":"Bang","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/ard.2007.082669","article-title":"Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis","volume":"67","author":"Mikuls","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30186-BIB25|cit25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1002\/art.30186-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.480","article-title":"Specific interaction between genotype, smoking and autoimmunity to citrullinated \u03b1-enolase in the etiology of rheumatoid arthritis","volume":"41","author":"Mahdi","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/art.30186-BIB27|cit27","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated \u03b1-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30186-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.23618","article-title":"Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis","volume":"58","author":"Kinloch","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB29|cit29","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated \u03b1-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB30|cit30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30186-BIB31|cit31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2007.10.002","article-title":"Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis","volume":"38","author":"Satpute","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB32|cit32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB33|cit33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","article-title":"Confidence interval estimation of interaction","volume":"3","author":"Hosmer","year":"1992","journal-title":"Epidemiology"},{"key":"10.1002\/art.30186-BIB34|cit34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.22373","article-title":"The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide","volume":"56","author":"Van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB35|cit35","first-page":"14","article-title":"Smoking in Spain, 1945-1995: a retrospective analysis based on the Spanish National Health Interview Surveys","volume":"120","author":"Fernandez","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1002\/art.30186-BIB36|cit36","first-page":"557","article-title":"Mortality associated to tobacco consumption in Galicia, Spain, 2001-2006","volume":"83","author":"Perez-Rios","year":"2009","journal-title":"Rev Esp Salud Publica"},{"key":"10.1002\/art.30186-BIB37|cit37","first-page":"23","article-title":"Mortality attributable to smoking in Spain in 2006","volume":"33","author":"Hernandez-Garcia","year":"2010","journal-title":"An Sist Sanit Navar"},{"key":"10.1002\/art.30186-BIB38|cit38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/rheumatology\/39.8.844","article-title":"Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid","volume":"39","author":"Balsa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30186-BIB39|cit39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K","article-title":"Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition","volume":"44","author":"Pascual","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB40|cit40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.smim.2006.03.009","article-title":"PTPN22: setting thresholds for autoimmunity","volume":"18","author":"Gregersen","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1002\/art.30186-BIB41|cit41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","article-title":"Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis","volume":"80","author":"Kallberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1002\/art.30186-BIB42|cit42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","article-title":"Citrullination in extra-articular manifestations of rheumatoid arthritis","volume":"46","author":"Bongartz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30186-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.2005.049403","article-title":"Citrullination is an inflammation-dependent process","volume":"65","author":"Makrygiannakis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30186-BIB44|cit44","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/art.22983","article-title":"Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation","volume":"56","author":"Foulquier","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30186-BIB45|cit45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.mehy.2008.12.040","article-title":"Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis","volume":"72","author":"Liao","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1002\/art.30186-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3899\/jrheum.091323","article-title":"Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives","volume":"37","author":"Hitchon","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30186-BIB47|cit47","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","article-title":"Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles","volume":"56","author":"Verpoort","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30186","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30186\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T21:49:30Z","timestamp":1712008170000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,25]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30186","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9558956.10375056","asserted-by":"object"}]},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,25]]}}}